Following administration of the COX inhibitor, indomethacin, IL-23-driven arthritic pain was prevented (Fig. 5E), which is consistent with our previous findings using an IL-23-driven inflammatory pain model [3]; interestingly, indomethacin also inhibited somewhat the progression of IL-23-driven arthritis (Fig. 5F). This evidence concerns the gene IL23A and arthritic joint disease.